Showing results (2961-2970 of 3,371) with videos related to
Sort By:
Pageof 338
ESC Heart Failure|April 27, 2019
Prognostic value of exercise myocardial deformation and haemodynamics in long-term heart-transplanted patientsTor Skibsted Clemmensen, Hans Eiskjaer, Brian Bridal Løgstrup, et al.ESC Heart Failure|July 28, 2018
Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniquesAlwin Zweerink, Wouter M van Everdingen, Robin Nijveldt, et al.ESC Heart Failure|July 28, 2018
Protein-losing enteropathy in an adult with non-ischaemic cardiomyopathy: complete reversal by heart transplantationVojtech Melenovsky, Milos Kubanek, Petr KacerESC Heart Failure|April 29, 2017
Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysisLisa J Alma, Anouk Bokslag, Angela H E M Maas, et al.ESC Heart Failure|April 29, 2017
Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient settingFernando Chernomordik, Dov Freimark, Michael Arad, et al.ESC Heart Failure|April 29, 2017
Abnormal haemodynamic postural response in patients with chronic heart failureAnne-Sophie G T Bronzwaer, Lysander W J Bogert, Berend E Westerhof, et al.ESC Heart Failure|April 29, 2017
Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013Jon V Norvik, Henrik Schirmer, Kirsti Ytrehus, et al.ESC Heart Failure|April 29, 2017
Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditisFriedrich Fruhwald, Dirk Lassner, Sonja Fruhwald, et al.ESC Heart Failure|April 20, 2018
Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathyFabian Muehlberg, Stephanie Funk, Leonora Zange, et al.ESC Heart Failure|September 27, 2016
Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2Anika Tschirner, Sandra Palus, Roland Hetzer, et al.Pageof 338